~~<i id='3138D99978'><strike id='3138D99978'><tt id='3138D99978'><pre id='3138D99978'></pre></tt></strike></i>~~

Home» focus» leisure time

leisure time

author：hotspot 2025-09-30 04:09:18 Page View：2

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： For Medicare Advantage, Democrats want stronger protections around AI
Next article： DIEP, the 'gold standard' of breast reconstruction, is under threat

explore

United colonoscopy coverage change 'may cost lives,' doctors say

AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

Why did Pfizer dish out millions for a Super Bowl ad?

Pfizer'sSuperBowladshowedcompanyfoundersCharlesPfizerandCharlesErhartsingingQueen’s“Don’tStopMeNow"a

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

Inaction leaves children at risk from dangerous chemotherapy drug

EvangelineGallagher/TBIJAyearafteraninvestigationrevealedwidespreaduseofasubstandardcancerdrug,theWo